| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,059 |
3,731 |
$138K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,492 |
4,980 |
$130K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,610 |
7,362 |
$113K |
| 80061 |
Lipid panel |
8,425 |
8,130 |
$101K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,575 |
1,455 |
$77K |
| 80053 |
Comprehensive metabolic panel |
7,006 |
6,679 |
$65K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,905 |
8,228 |
$59K |
| 36415 |
Collection of venous blood by venipuncture |
8,553 |
7,713 |
$51K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,306 |
1,269 |
$34K |
| 86328 |
|
1,682 |
1,567 |
$31K |
| 81000 |
|
9,890 |
9,373 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,359 |
3,240 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,826 |
2,685 |
$21K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
600 |
559 |
$19K |
| 86703 |
|
1,520 |
1,447 |
$18K |
| 84439 |
|
2,181 |
2,093 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
507 |
469 |
$16K |
| 85027 |
|
2,473 |
2,351 |
$14K |
| 82043 |
|
2,634 |
2,500 |
$13K |
| 84153 |
|
758 |
737 |
$12K |
| 82274 |
|
861 |
819 |
$12K |
| 87088 |
|
1,576 |
1,473 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
922 |
434 |
$11K |
| 84436 |
|
1,555 |
1,508 |
$9K |
| 82607 |
|
630 |
601 |
$8K |
| 84479 |
|
1,210 |
1,169 |
$7K |
| 82947 |
|
1,784 |
1,738 |
$6K |
| 86592 |
|
1,215 |
1,159 |
$5K |
| 82570 |
|
747 |
697 |
$3K |
| 80074 |
|
56 |
55 |
$3K |
| 85004 |
|
441 |
429 |
$2K |
| 87276 |
|
209 |
207 |
$2K |
| 87275 |
|
209 |
207 |
$2K |
| 85651 |
|
580 |
566 |
$2K |
| 85730 |
|
329 |
300 |
$2K |
| 85610 |
|
371 |
340 |
$1K |
| 85041 |
|
411 |
399 |
$992.59 |
| 80050 |
General health panel |
96 |
96 |
$954.22 |
| 83001 |
|
42 |
42 |
$722.01 |
| 86769 |
|
24 |
23 |
$714.73 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$615.96 |
| 86038 |
|
43 |
40 |
$458.10 |
| 84550 |
|
121 |
114 |
$447.04 |
| 83002 |
|
24 |
24 |
$433.49 |
| 84146 |
|
14 |
13 |
$243.73 |
| 84703 |
|
40 |
38 |
$231.11 |
| 85049 |
|
63 |
63 |
$225.44 |
| 87340 |
|
25 |
25 |
$224.89 |
| 86803 |
|
21 |
14 |
$191.46 |
| 85018 |
|
77 |
77 |
$155.72 |
| 82270 |
|
41 |
40 |
$104.58 |
| 82565 |
|
29 |
28 |
$102.03 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
14 |
$85.81 |
| 84520 |
|
28 |
27 |
$74.14 |
| 84460 |
|
14 |
13 |
$47.36 |
| 84450 |
|
14 |
13 |
$46.25 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
255 |
215 |
$0.00 |